Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01441817
Other study ID # 224-01077(REK)
Secondary ID REK
Status Completed
Phase N/A
First received September 15, 2011
Last updated September 27, 2011
Start date May 2002
Est. completion date August 2008

Study information

Verified date September 2011
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority Norway: The Regional Ethics Committee for Medical Research
Study type Interventional

Clinical Trial Summary

The purpose of this study was to determine if internal fixation of the medial malleolus is necessary following open reduction and internal fixation of the lateral and, if required, the posterior malleolus treating displaced bi-or trimalleolar ankle fractures.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date August 2008
Est. primary completion date August 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with Orthopaedic Trauma Association (OTA) type 44 fractures (B2-3 and C2-3).

Exclusion Criteria:

- Patients with OTA type 43 distal tibia fractures.

- Patients with soft tissue injuries involving the medial malleolus.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Internal fixation
Internal fixation of the medial malleolus following open reduction and internal fixation of the lateral and, if required, posterior malleolus.

Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (1)

Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary American Orthopaedic Foot and Ankle Society ankle hind foot score (AOFAS) Average of 42 months No
Primary The Olerud Molander Ankle score (OMAS) Average of 42 months No
Secondary Posttraumatic osteoarthritis (OA) according to the criteria of Magnusson (stage I-IV) Average of 42 months No
Secondary VAS score Pain evaluated at rest, in the morning, in the evening and during the night. Average of 42 months No
See also
  Status Clinical Trial Phase
Completed NCT01616173 - Analgesic Benefits of Perineural Versus Intravenous Dexamethasone in Patients Receiving Sciatic Nerve Block Phase 4